Csaba Pál

14.3k total citations · 2 hit papers
93 papers, 7.4k citations indexed

About

Csaba Pál is a scholar working on Molecular Biology, Genetics and Molecular Medicine. According to data from OpenAlex, Csaba Pál has authored 93 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Biology, 47 papers in Genetics and 14 papers in Molecular Medicine. Recurrent topics in Csaba Pál's work include Evolution and Genetic Dynamics (31 papers), CRISPR and Genetic Engineering (18 papers) and RNA and protein synthesis mechanisms (15 papers). Csaba Pál is often cited by papers focused on Evolution and Genetic Dynamics (31 papers), CRISPR and Genetic Engineering (18 papers) and RNA and protein synthesis mechanisms (15 papers). Csaba Pál collaborates with scholars based in Hungary, United Kingdom and United States. Csaba Pál's co-authors include Balázs Papp, Laurence D. Hurst, Martin J. Lercher, Viktória Lázár, Ákos Nyerges, Bálint Csörgő, Gergely Fekete, Angus Buckling, Stephen G. Oliver and István Nagy and has published in prestigious journals such as Nature, Science and Chemical Reviews.

In The Last Decade

Csaba Pál

91 papers receiving 7.4k citations

Hit Papers

Dosage sensitivity and the evolution of gene families in ... 2003 2026 2010 2018 2003 2004 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Csaba Pál Hungary 43 5.4k 2.7k 989 791 636 93 7.4k
Balázs Papp Hungary 41 5.0k 0.9× 1.9k 0.7× 763 0.8× 476 0.6× 534 0.8× 84 6.5k
François Taddéi France 41 4.4k 0.8× 3.8k 1.4× 649 0.7× 1.2k 1.5× 662 1.0× 76 7.3k
Jan‐Willem Veening Netherlands 45 4.2k 0.8× 2.8k 1.0× 743 0.8× 1.4k 1.7× 593 0.9× 122 6.9k
Ivan Matić France 40 3.4k 0.6× 2.7k 1.0× 443 0.4× 659 0.8× 1.1k 1.7× 97 5.7k
Martijn A. Huynen Netherlands 65 10.6k 2.0× 2.5k 0.9× 1.2k 1.2× 1.4k 1.7× 156 0.2× 225 13.2k
J. Peter Gogarten United States 45 6.7k 1.2× 1.7k 0.6× 1.8k 1.8× 2.9k 3.7× 326 0.5× 157 9.1k
Miroslav Radman France 62 10.6k 2.0× 5.0k 1.9× 1.5k 1.5× 1.5k 1.8× 749 1.2× 174 13.9k
Tomoya Baba Japan 24 6.6k 1.2× 4.3k 1.6× 1.7k 1.8× 1.2k 1.5× 759 1.2× 43 9.3k
Jihyun F. Kim South Korea 42 3.0k 0.5× 1.3k 0.5× 2.3k 2.3× 884 1.1× 169 0.3× 102 6.3k
Susan M. Rosenberg United States 47 5.7k 1.1× 4.6k 1.7× 782 0.8× 649 0.8× 894 1.4× 114 7.5k

Countries citing papers authored by Csaba Pál

Since Specialization
Citations

This map shows the geographic impact of Csaba Pál's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Csaba Pál with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Csaba Pál more than expected).

Fields of papers citing papers by Csaba Pál

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Csaba Pál. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Csaba Pál. The network helps show where Csaba Pál may publish in the future.

Co-authorship network of co-authors of Csaba Pál

This figure shows the co-authorship network connecting the top 25 collaborators of Csaba Pál. A scholar is included among the top collaborators of Csaba Pál based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Csaba Pál. Csaba Pál is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cotman, Andrej Emanuel, Davide Benedetto Tiz, Žiga Skok, et al.. (2024). New N-phenylpyrrolamide inhibitors of DNA gyrase with improved antibacterial activity. RSC Advances. 14(39). 28423–28454. 1 indexed citations
2.
Durcik, Martina, Clare E. M. Stevenson, Petra Szili, et al.. (2023). Exploring the 5-Substituted 2-Aminobenzothiazole-Based DNA Gyrase B Inhibitors Active against ESKAPE Pathogens. ACS Omega. 8(27). 24387–24395. 9 indexed citations
3.
Jangir, Pramod K., Petra Szili, Márton Simon Czikkely, et al.. (2023). The evolution of colistin resistance increases bacterial resistance to host antimicrobial peptides and virulence. eLife. 12. 23 indexed citations
4.
Nyerges, Ákos, et al.. (2021). ssDNA recombineering boosts in vivo evolution of nanobodies displayed on bacterial surfaces. Communications Biology. 4(1). 1169–1169. 7 indexed citations
5.
Wannier, Timothy M., Andrew D. Ellington, Gabriel Filsinger, et al.. (2021). Recombineering and MAGE. Nature Reviews Methods Primers. 1(1). 64 indexed citations
6.
Bálint, Anita, Klaudia Farkas, Orsolya Méhi, et al.. (2020). Functional Anatomical Changes in Ulcerative Colitis Patients Determine Their Gut Microbiota Composition and Consequently the Possible Treatment Outcome. Pharmaceuticals. 13(11). 346–346. 20 indexed citations
7.
Csörgő, Bálint, Ákos Nyerges, & Csaba Pál. (2020). Targeted mutagenesis of multiple chromosomal regions in microbes. Current Opinion in Microbiology. 57. 22–30. 12 indexed citations
8.
Durcik, Martina, Žiga Skok, Janez Ilaš, et al.. (2020). Hybrid Inhibitors of DNA Gyrase A and B: Design, Synthesis and Evaluation. Pharmaceutics. 13(1). 6–6. 13 indexed citations
9.
Wannier, Timothy M., Ákos Nyerges, Márton Simon Czikkely, et al.. (2020). Improved bacterial recombineering by parallelized protein discovery. Proceedings of the National Academy of Sciences. 117(24). 13689–13698. 89 indexed citations
10.
Spohn, Réka, Zoltán Farkas, Viktória Lázár, et al.. (2019). Rapid decline of bacterial drug-resistance in an antibiotic-free environment through phenotypic reversion. eLife. 8. 67 indexed citations
11.
Nyerges, Ákos, et al.. (2019). CRISPR-interference-based modulation of mobile genetic elements in bacteria. PubMed. 4(1). ysz008–ysz008. 14 indexed citations
12.
Tiz, Davide Benedetto, Žiga Skok, Martina Durcik, et al.. (2019). An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors. European Journal of Medicinal Chemistry. 167. 269–290. 42 indexed citations
13.
Nyerges, Ákos, et al.. (2019). Multiple-Site Diversification of Regulatory Sequences Enables Interspecies Operability of Genetic Devices. ACS Synthetic Biology. 9(1). 104–114. 15 indexed citations
14.
Guzmán, Gabriela I., Troy E. Sandberg, Ryan A. LaCroix, et al.. (2019). Enzyme promiscuity shapes adaptation to novel growth substrates. Molecular Systems Biology. 15(4). e8462–e8462. 60 indexed citations
15.
Szili, Petra, Gábor Draskovits, Tamás Révész, et al.. (2019). Rapid Evolution of Reduced Susceptibility against a Balanced Dual-Targeting Antibiotic through Stepping-Stone Mutations. Antimicrobial Agents and Chemotherapy. 63(9). 35 indexed citations
16.
Durcik, Martina, Žiga Skok, Cristina D. Cruz, et al.. (2018). New N -phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity. European Journal of Medicinal Chemistry. 154. 117–132. 32 indexed citations
17.
Nyerges, Ákos, Bálint Csörgő, Gábor Draskovits, et al.. (2018). Directed evolution of multiple genomic loci allows the prediction of antibiotic resistance. Proceedings of the National Academy of Sciences. 115(25). E5726–E5735. 63 indexed citations
18.
Kintses, Bálint, Orsolya Méhi, Eszter Ari, et al.. (2018). Phylogenetic barriers to horizontal transfer of antimicrobial peptide resistance genes in the human gut microbiota. Nature Microbiology. 4(3). 447–458. 75 indexed citations
19.
Papp, Balázs, Csaba Pál, & Laurence D. Hurst. (2004). Metabolic network analysis of the causes and evolution of enzyme dispensability in yeast. Nature. 429(6992). 661–664. 273 indexed citations
20.
Hurst, Laurence D. & Csaba Pál. (2001). Evidence for purifying selection acting on silent sites in BRCA1. Trends in Genetics. 17(2). 62–65. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026